Titles

Professor of Pharmaceutical Sciences

School Affiliation

School of Pharmacy

Specialties

• Drug Delivery
• Translational Research

About

410-706-2646 astinchc@rx.umaryland.edu

Dr. Audra Stinchcomb’s research is focused on transdermal prodrugs, microneedle-enhanced delivery, and translational research models for public-private partnerships. She has developed a research program in transdermal drug delivery in the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy that revolves around the examination of the mechanisms and optimization of prodrug skin permeation and microneedle-enhanced skin permeation. This research has studied the influence of prodrug physicochemical properties on skin flux, distribution, and metabolism. The results of this prodrug knowledge fueled the genesis of F6 Pharma, LLC, a transdermal specialty pharmaceutical company. Transdermal prodrugs are in development for treatment of cancer chemotherapy nausea and vomiting, alcoholism, drug addiction, and pain. Transdermal cannabinoid delivery has also been a major research focus, with new prodrugs developed to improve aqueous solubility, chemical stability, as well as skin permeation. The microneedle research focus has been on formulations for improved permeation rate and micropore lifetime, utilizing animal studies translated to human subject studies.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Research and Innovation  

This information was last updated January 5, 2023.